DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Halozyme Therapeutics
HALO
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
Precision Drilling
PDS
US Stock MarketDetailed Quotes
LLY Eli Lilly and Co
- 920.560
- +5.550+0.61%
Trading Feb 27 10:32 ET
872.85BMarket Cap78.61P/E (TTM)
925.500High907.320Low832.38KVolume914.800Open915.010Pre Close763.94MTurnover0.09%Turnover Ratio78.61P/E (Static)948.17MShares969.23352wk High61.50P/B872.03BFloat Cap710.16952wk Low5.20Dividend TTM947.29MShs Float969.233Historical High0.56%Div YieldTTM1.99%Amplitude5.269Historical Low917.780Avg Price1Lot Size
About Eli Lilly and Co Company
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Company Profile
SymbolLLY
Company NameEli Lilly and Co
Listing DateApr 1, 1973
Founded1876
CEOMr. David A. Ricks
MarketNYSE
Employees47000
Fiscal Year Ends12-31
AddressLilly Corporate Center
CityIndianapolis
ProvinceIndiana
CountryUnited States of America
Zip Code46285
Phone1-317-276-2000
Websitehttp://www.lilly.com
Company Executives
- Name
- Position
- Salary
- David A. Ricks
- Chairman of the Board, President and Chief Executive Officer
- 26.57M
- Eric Dozier
- Executive Vice President and Chief People Officer
- --
- Donald A. Zakrowski
- Senior Vice President, Finance and Chief Accounting Officer
- --
- Diogo Rau
- Executive Vice President, Chief Information Officer and Chief Digital Officer
- --
- Dr. Daniel M. Skovronsky, M.D.
- Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology
- 11.85M
- Lucas Montarce
- Executive Vice President and Chief Financial Officer
- --
- Ilya Yuffa
- Executive Vice President; President, Lilly International
- --
- Melissa Seymour
- Executive Vice President, Global Quality
- --
- Patrik Jonsson
- Executive Vice President and President, Lilly Cardiometabolic Health; President, Lilly USA
- --
- Anat Hakim
- Executive Vice President, General Counsel and Secretary
- 7.01M
- Jacob S. Van Naarden
- Executive Vice President and President, Lilly Oncology
- 4.89M
- Edgardo Hernandez
- Executive Vice President and President, Manufacturing Operations
- --
- Anne E. White
- Executive Vice President and President, Lilly Neuroscience
- --
- Ralph Alvarez
- Independent Director
- 336.00K
- Juan R. Luciano
- Lead Independent Director
- 373.00K
- Gabrielle Sulzberger, J.D.,M.B.A.
- Independent Director
- 335.50K
- Jon Erik Fyrwald
- Independent Director
- 344.88K
- Dr. William G. Kaelin, Jr
- Independent Director
- 349.15K
- Kimberly H. Johnson
- Independent Director
- 316.00K
- Dr. Mary Lynne Hedley,PhD
- Independent Director
- 319.00K
- Jamere Jackson
- Independent Director
- 345.00K
- Dr. Katherine Baicker, PhD
- Independent Director
- 336.00K
- Jon R. Moeller
- Independent Director
- --
